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Solitary fibrous tumors (SFTs) are rare tumors, first described as pleural tumors of mesothelial origin. Extrapleural SFTs deriving from fibro-
blast-like cells1 are an even more unusual variant.
We report a case of leg SFT and provide some 
clues for preoperative diagnosis and treatment plan.
CASE	REPORT
A 37-year-old man presented with 2 painful lumps 
on the distal third of his left leg, which had appeared 
2 years before and had grown progressively. One was 
on the anterolateral surface (8.5 × 7 cm), the other 
in the medial supramalleolar region (6 × 5 cm); both 
had regular ill-defined margins, hard consistency, 
and were fixed to the deep structures while gliding 
on the skin. Clinical examination showed a pulse 
synchronous with the peripheral pulses and a corre-
sponding systolic murmur, confirmed with an 8-MHz 
Doppler probe, that allowed to trace the anterior 
(ATV) and posterior tibial vessels (PTV) entering 
the mass and exiting from it distally, mimicking an 
arteriovenous malformation. A preoperative ultra-
sound was suggestive for liquid content of the mass.
The magnetic resonance imaging (MRI) scan 
showed an hourglass-shaped mass that seemed to 
involve the peroneal artery, 6.6-cm diameter, fed by 
branches of the ATV and PTV. The mass seemed to 
have clear-defined margins and expanding growth. 
Angiography showed the peroneal artery entering 
the mass and branches from the anterior and poste-
rior tibial arteries nourishing it (Fig.1).
The preoperative diagnosis was of a tumoral 
mass of vascular origin. Transperoneal removal 
was planned through 3 accesses: lateral, demoli-
tive transperoneal approach for interosseous space 
and peroneal and tibial vessels exposure; anterior, 
to expose the anterior portion of the mass and the 
ATV; extended medial retromalleolar approach, to 
expose the mass and the PTV (Fig. 2).
During surgery, antibiotic prophylaxis was 
performed2 and a white, hard mass was exposed 
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Summary: Solitary fibrous tumor (SFT) is a rare neoplasm that commonly 
originates in the pleura. Extrapleural locations are rare and for this rea-
son sometimes difficult to diagnose. Malignant forms with local recurrence 
or distant metastases have been reported, also as a consequence of inap-
propriate treatment. In this article, we report the case of an SFT of the 
lower leg in a 37-year-old man. Leg SFT is a rare occurrence, and differ-
ential diagnosis may be difficult because they can mimic a variety of be-
nign and malignant mesenchymal tumors; immunohistochemical analysis 
for CD34, CD99, vimentin, and Bcl-2 is necessary. Misdiagnosis carries a 
significant risk of inadequate removal with subsequent increased risk of re-
currence and distant metastases. (Plast Reconstr Surg Glob Open 2015;3:e528; 
doi: 10.1097/GOX.0000000000000501; Published online 1 October 2015.)
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(Figs. 1, 2). Frozen sections revealed a tumoral 
lesion with a vascular component. The mass was 
radically removed and sent for definitive pathol-
ogy. The patient was immobilized for 5 days with 
gradual resumption of load.
The final pathology report revealed an SFT of 
mixed cellularity with clear margins and the follow-
ing immunohistochemistry profile: CD34+, Bcl-2+, 
CD99±, CD31−, CK7−, Ki67 <5%. The patient under-
went postoperative radiotherapy (54 Gy). At a 5-year 
follow-up, the patient is alive and free from disease; 
he complains only of a slight functional limitation 
and a limb swelling and a feeling of heaviness after 
a prolonged period of standing. His postoperative 
Lower Extremity Functional Scale score is 72/803.
DISCUSSION
The case reported is a rare disease that can mimic 
more common lesions; it might pass unsuspected, 
making surgical planning inappropriate. The pur-
pose of this manuscript is to raise awareness about 
SFT and provide clues for diagnosis and treatment 
in such difficult anatomic location. SFTs lack specific 
radiological features: on x-ray, they are radiopaque; 
on ultrasound, they seem as a nodule with well-de-
fined edges and a homogenous echostructure.4 The 
case reported shows how clinical and imaging data 
might be misleading. MRI shows an intermediate sig-
nal intensity in T1 and a heterogeneous low signal 
with empty flow in T2 and contrast enhancement. 
Nonenhancing central areas and long, tortuous ves-
sels support diagnosis. MRI allows differential diag-
nosis with vascular malformations (VMs): Low-flow 
VMs show heightened signal intensity on T2; high-
flow VMs have an empty signal. A definitive diagno-
sis of SFT can only be achieved through histological 
and immunohistochemical studies. Histological fea-
tures of soft tissue SFTs are frequently referred to as 
“patternless,” characterized by numerous thin-walled 
ramifying blood vessels, with a partial “staghorn” con-
figuration, with spindle cell areas arranged in short, 
ill-defined fascicles, or randomly with areas of strik-
ing hyalinization with cells surrounding ramifying 
vascular network. CD34 immunoreactivity is strong 
Fig. 1. this figure compares the resected specimen (a) with the MRI (B) and arteriography (C). the hourglass shape, due 
to the footprint of the interosseous membrane, is clearly visible in both a and B. the MRI shows a well-defined, homoge-
neously intense mass, findings suggestive of a tumoral lesion with expansile growth. the arteriography shows a peroneal 
artery that seems to end in the mass and the branches from the ptV and atV that nourish the mass.
Fig. 2. Lateral view after fibula removal. this access provides 
wide exposure of the interosseous space and full control on 
the atV and ptV and peroneal vessels, together with the tibi-
al nerve. the mass is visible on the distal part of the field close 
to the tip of the retractor that holds the peroneal and anteri-
or tibial muscles and the anterior neurovascular bundle. the 
planned peroneal vessels resection excluded preservation of 
the devascularized fibular segment removed for exposure 
because a 12-cm nonvascularised graft would have carried a 
high risk of failure and pseudoarthrosis.
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and diffuse as well as positive for Bcl-2 and CD99. 
Negative immunohistochemical stainings for vimen-
tin, cytokeratins, smooth muscle actin, epithelial an-
tigen membrane, desmin, c-kit (CD117), and S-100 
protein are sometimes useful for differential diag-
nosis of SFT from tumors of muscle, epithelial, or 
neural origin.1 The lack of a specific growth pattern 
in an SFT lesion makes the differential diagnosis of-
ten challenging. Due to the similar growth pattern, 
SFT and hemangiopericytomas are considered the 
same entity by Gengler and Guillou, Fletcher, and 
Fletcher et al,1,5,6 and the term hemangiopericytoma 
has been abandoned. SFTs are “typical” or “malig-
nant” based on number of mitoses, cellular atypia, 
presence of necrosis, and hypercellularity. SFTs can 
occur in every anatomic location. Most case series 
showed almost equal distribution for male and fe-
male patients, with ages ranging from the third to 
the eighth or ninth decade with a maximum inci-
dence in the fifth to sixth decade.1,7
SFTs have a slow growth rate and rarely tend to 
metastatize,7 behaving aggressively in 10–31% of 
cases. Recurrences range from 20–36%.8 Incomplete 
resection leads to local and distant recurrences. Al-
though they might seem encapsulated, these lesions 
cannot be just enucleated or the risk of recurrence 
will be too high.9 For a radical resection to be ob-
tained, an appropriately wide exposure is mandato-
ry. In this case, 3 incisions and removal of the fibula 
were necessary to remove the mass without disrupt-
ing it and causing potential spread or sacrificing 
radicality of resection. Furthermore, this exposure 
facilitates vessels exposure and control.
CONCLUSIONS
Leg SFTs are a rare occurrence and can mimic 
VM. These tumors must be taken into account in 
cases of hard masses of likely vascular origin that 
show uncertain features on MRI. In the interosse-
ous region of the lower leg, wide exposure using a 
conservative transperoneal access and multiple inci-
sions when needed allow to achieve good control of 
the mass.
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